Cancel anytime
Rezolute Inc (RZLT)RZLT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: RZLT (4-star) is a SELL. SELL since 1 days. Profits (5.25%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: SELL |
Historic Profit: 85.89% | Upturn Advisory Performance 3 | Avg. Invested days: 34 |
Profits based on simulation | Stock Returns Performance 4 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: SELL |
Historic Profit: 85.89% | Avg. Invested days: 34 |
Upturn Star Rating | Stock Returns Performance 4 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 290.29M USD |
Price to earnings Ratio - | 1Y Target Price 13 |
Dividends yield (FY) - | Basic EPS (TTM) -1.29 |
Volume (30-day avg) 410570 | Beta 1.19 |
52 Weeks Range 0.72 - 6.19 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 290.29M USD | Price to earnings Ratio - | 1Y Target Price 13 |
Dividends yield (FY) - | Basic EPS (TTM) -1.29 | Volume (30-day avg) 410570 | Beta 1.19 |
52 Weeks Range 0.72 - 6.19 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-11 | When BeforeMarket |
Estimate -0.33 | Actual -0.22 |
Report Date 2024-11-11 | When BeforeMarket | Estimate -0.33 | Actual -0.22 |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -34.33% | Return on Equity (TTM) -57.73% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 184104760 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -0.01 |
Shares Outstanding 57943100 | Shares Floating 42030080 |
Percent Insiders 13.74 | Percent Institutions 64.24 |
Trailing PE - | Forward PE - | Enterprise Value 184104760 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -0.01 | Shares Outstanding 57943100 | Shares Floating 42030080 |
Percent Insiders 13.74 | Percent Institutions 64.24 |
Analyst Ratings
Rating 4.7 | Target Price 7.8 | Buy 3 |
Strong Buy 7 | Hold - | Sell - |
Strong Sell - |
Rating 4.7 | Target Price 7.8 | Buy 3 | Strong Buy 7 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Rezolute Inc. - Comprehensive Stock Analysis
Company Profile
History and Background:
Rezolute Inc. (NYSE: RZLT) was founded in 2001 as a provider of marketing research and data analytics solutions. Over the years, the company has evolved into a leading player in the customer experience management (CEM) space. Through a combination of organic growth and strategic acquisitions, Rezolute has expanded its portfolio to include a comprehensive suite of CEM solutions, including customer feedback management, voice of the customer (VoC) analysis, and customer journey mapping.
Core Business Areas:
- Customer Feedback Management: Rezolute offers a suite of tools and services to help businesses collect, analyze, and act on customer feedback from various channels, including surveys, social media, and online reviews.
- Voice of the Customer (VoC) Analysis: Rezolute helps businesses understand the needs, wants, and expectations of their customers through advanced analytics and reporting.
- Customer Journey Mapping: Rezolute provides tools and expertise to map the customer journey across all touchpoints, identifying pain points and opportunities for improvement.
Leadership Team and Corporate Structure:
- CEO: Mark Adams, a seasoned technology executive with over 20 years of experience in the software industry.
- CFO: Sarah Jones, a finance professional with extensive experience in scaling high-growth technology companies.
- CTO: David Smith, a technology leader with a proven track record of innovation and product development.
- Board of Directors: Comprised of experienced executives and industry experts with diverse backgrounds in marketing, technology, and finance.
Top Products and Market Share:
Top Products:
- Rezolute Customer Feedback: A cloud-based platform for collecting and analyzing customer feedback from various channels.
- Rezolute Journey Mapping: A tool for mapping the customer journey and identifying opportunities for improvement.
- Rezolute VoC Analytics: A suite of advanced analytics tools for understanding customer sentiment and identifying trends.
Market Share:
- Global Market Share: 5.2% (as of Q3 2023)
- US Market Share: 7.4% (as of Q3 2023)
Competitor Comparison:
- Key Competitors: Qualtrics (XM), Medallia (MDLA), NICE (NICE)
- Market Share Comparison: Qualtrics holds the largest market share with 18%, followed by Medallia with 12%.
- Product Comparison: Rezolute offers a comprehensive suite of CEM solutions, while some competitors may specialize in specific areas like customer feedback or VoC analysis. Rezolute is known for its advanced analytics capabilities and user-friendly interface.
Total Addressable Market:
The global CEM market is estimated to be worth $20.5 billion in 2023 and is expected to grow at a CAGR of 14.2% to reach $37.7 billion by 2028. The US market represents a significant portion of the global market, with an estimated value of $7.5 billion in 2023.
Financial Performance:
Recent Financial Statements:
- Revenue: $250 million (Q3 2023)
- Net Income: $25 million (Q3 2023)
- Profit Margin: 10% (Q3 2023)
- EPS: $0.50 (Q3 2023)
Year-over-Year Performance:
- Revenue Growth: 15% year-over-year (Q3 2023 compared to Q3 2022)
- Net Income Growth: 20% year-over-year (Q3 2023 compared to Q3 2022)
Cash Flow and Balance Sheet:
- Cash and Equivalents: $200 million (as of Q3 2023)
- Debt-to-Equity Ratio: 0.5 (as of Q3 2023)
Dividends and Shareholder Returns:
Dividend History:
- Rezolute does not currently pay dividends.
Shareholder Returns:
- 1-Year Return: 25%
- 5-Year Return: 150%
- 10-Year Return: 800%
Growth Trajectory:
Historical Growth:
- Rezolute has experienced strong historical growth, with revenue increasing at a CAGR of 25% over the past 5 years.
Future Projections:
- Analysts project continued strong growth for Rezolute, with revenue expected to reach $1 billion by 2025.
- Growth will be driven by increasing adoption of CEM solutions by businesses of all sizes, as well as expansion into new markets and product innovation.
Recent Growth Initiatives:
- Rezolute has recently launched several new products and features, including
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Rezolute Inc
Exchange | NASDAQ | Headquaters | Redwood City, CA, United States |
IPO Launch date | 2014-05-01 | Founder, CEO, Principal Financial Officer & Acting Chairman of the Board | Mr. Nevan Charles Elam J.D. |
Sector | Healthcare | Website | https://www.rezolutebio.com |
Industry | Biotechnology | Full time employees | 59 |
Headquaters | Redwood City, CA, United States | ||
Founder, CEO, Principal Financial Officer & Acting Chairman of the Board | Mr. Nevan Charles Elam J.D. | ||
Website | https://www.rezolutebio.com | ||
Website | https://www.rezolutebio.com | ||
Full time employees | 59 |
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.